Taiwan: Supreme Court’s new decision on contract manufacturers’ infringement liabilities

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: Supreme Court’s new decision on contract manufacturers’ infringement liabilities

One feature of Taiwan's Patent Law (and all the country's IP laws) that many patentees find interesting is the lack of indirect infringement. To seek remedies against suppliers (mainly contract manufacturers, or CMs) of essential elements of a patented invention, patentees need resort to the Civil Code rules regarding the liabilities for assisting torts.

Under the Civil Code, liabilities of an assistant (such as a CM) are established if the following requirements are met: the existence of another party (such as the buyer) having been proved to be a direct infringer, the assistant's conduct, the proximate causation between the assistance and the tortious result, and the assistant's negligence or intention behind its conduct.

The substitute provided by the Civil Code is of course less ideal than the contributory liability principles adopted by other jurisdictions, such as the US and Japan. However, this gap can gradually be mitigated by court decisions, as judges have the power to recalibrate the interpretation of the prerequisites of assistants' liabilities in real cases – in a direction that's friendlier to patentees. Judges are also willing to do this as it helps Taiwan to keep abreast of international trends before the next round of patent law amendments take effect, which embrace the contributory liability principle (momentum is growing in this area). The most recent initiative is a decision issued by Taiwan's Supreme Court at the end of January 2019 addressing how assistants' intention/negligence should be determined Zhuang v Kuan Sheng Aluminum Mold Co., Ltd., 107 Tai Shang 1781 (2019 Taiwan St. Ct.).

The disputed patent in Zhuang v Kuan Sheng related to a grid plate-tightening device for water barriers, an invention said to meet the needs of residents in Taiwan's coastal areas affected by typhoon floods. The alleged infringing products were assembled and sold by an end dealer that had been separately sued and proven to be directly infringing the patent. A large portion of the components of the end product, however, were produced by a CM, and it was this CM that was sued in Zhuang under the principle of assistant's liability.

Interestingly, the CM did not contend much on whether the components it supplied were essential to the patent or, to rephrase it in the assistant's liability context, whether it actually assisted the direct infringer with the manufacturing. Instead, the CM argued that the mental state requirement was lacking: "We do not specialise in water barrier productions and we have no R&D group. Other than relying on the buyer's non-infringement guarantee letter (provided after the CM received the patentee's warning letter) we had no ability to look into whether the water barrier along with the affiliated components we supplied was patent infringing."

This line of argument was accepted by a second instance panel of the IP Court, a result quite welcome by small and medium-sized CMs as they now conceivably have a better chance to be released from the duty to verify whether or not the components they supply are used to infringe a patent. At least, these CMs will be allowed to rely upon a buyer's guarantee to establish a lack-of-negligence contention. However, but is this really the case?

The Supreme Court's answer was no: "The respondent (the CM) is not objectively unable to analyse whether the infringement allegation of the petitioner (the patentee) is true, and to get an analysis is not difficult at all. The respondent cannot evade the verification duty by simply relying on its buyer's assertion and then continue its contract manufacturing for the buyer." The IP Court's decision was therefore revoked and remanded for further investigation into whether the CM was negligent or wilful in helping the buyer with infringing the patent.

As the decision suggested, whatever their business size, CMs shall take responsibility for their own conduct and their infringement liabilities shall be determined independently of direct infringers' activities – these are the same ideas that give birth to the contributory liability theory. Although it will still take time for the contributory liability theory to take root in Taiwan's IP law regime, the Supreme Court's decision in Zhuang v Kuan Sheng made noticeable progress in clearing the field of patent law for that borrowed theory to grow.

chang-tony.jpg

Tony Tung-Yang Chang


Saint Island International Patent & Law Offices7th Floor, No. 248, Section 3Nanking East RoadTaipei 105-45, Taiwan, ROCTel: +886 2 2775 1823Fax: +886 2 2731 6377siiplo@mail.saint-island.com.twwww.saint-island.com.tw

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article